- Home
- ALZN vs FRSX Comparison
ALZN vs FRSX Comparison
Compare ALZN & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- FRSX
- Stock Information
- Founded
- ALZN 2016
- FRSX N/A
- Country
- ALZN United States
- FRSX Israel
- Employees
- ALZN N/A
- FRSX N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- FRSX Computer Software: Prepackaged Software
- Sector
- ALZN Health Care
- FRSX Technology
- Exchange
- ALZN Nasdaq
- FRSX Nasdaq
- Market Cap
- ALZN 7.5M
- FRSX 7.1M
- IPO Year
- ALZN 2021
- FRSX 2017
- Fundamental
- Price
- ALZN $2.35
- FRSX $2.30
- Analyst Decision
- ALZN Strong Buy
- FRSX
- Analyst Count
- ALZN 1
- FRSX 0
- Target Price
- ALZN $42.00
- FRSX N/A
- AVG Volume (30 Days)
- ALZN 132.3K
- FRSX 53.5K
- Earning Date
- ALZN 12-11-2025
- FRSX 11-28-2025
- Dividend Yield
- ALZN N/A
- FRSX N/A
- EPS Growth
- ALZN N/A
- FRSX N/A
- EPS
- ALZN N/A
- FRSX N/A
- Revenue
- ALZN N/A
- FRSX $452,000.00
- Revenue This Year
- ALZN N/A
- FRSX N/A
- Revenue Next Year
- ALZN N/A
- FRSX N/A
- P/E Ratio
- ALZN N/A
- FRSX N/A
- Revenue Growth
- ALZN N/A
- FRSX N/A
- 52 Week Low
- ALZN $2.06
- FRSX $1.98
- 52 Week High
- ALZN $15.21
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- ALZN 48.08
- FRSX 54.81
- Support Level
- ALZN $2.27
- FRSX $2.24
- Resistance Level
- ALZN $2.56
- FRSX $2.58
- Average True Range (ATR)
- ALZN 0.16
- FRSX 0.16
- MACD
- ALZN 0.01
- FRSX -0.03
- Stochastic Oscillator
- ALZN 50.71
- FRSX 30.50
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.